These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 11232713)

  • 1. Consecutive occurrence of primary biliary cirrhosis and autoimmune hepatitis: a case report and review of the literature.
    Weyman RL; Voigt M
    Am J Gastroenterol; 2001 Feb; 96(2):585-7. PubMed ID: 11232713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid.
    Joshi S; Cauch-Dudek K; Wanless IR; Lindor KD; Jorgensen R; Batts K; Heathcote EJ
    Hepatology; 2002 Feb; 35(2):409-13. PubMed ID: 11826416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation.
    Kim WR; Poterucha JJ; Jorgensen RA; Batts KP; Homburger HA; Dickson ER; Krom RA; Wiesner RH; Lindor KD
    Hepatology; 1997 Jul; 26(1):22-6. PubMed ID: 9214447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis.
    Liu B; Shi XH; Zhang FC; Zhang W; Gao LX
    Liver Int; 2008 Feb; 28(2):233-9. PubMed ID: 18251980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution from primary biliary cirrhosis to primary biliary cirrhosis/autoimmune hepatitis overlap syndrome.
    Twaddell WS; Lefkowitch J; Berk PD
    Semin Liver Dis; 2008 Feb; 28(1):128-34. PubMed ID: 18293283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transitions between variant forms of primary biliary cirrhosis during long-term follow-up.
    Lindgren S; Glaumann H; Almer S; Bergquist A; Björnsson E; Broomé U; Danielsson A; Lebrun B; Prytz H; Olsson R
    Eur J Intern Med; 2009 Jul; 20(4):398-402. PubMed ID: 19524182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
    Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overlap syndrome: autoimmune hepatitis with primary biliary cirrhosis.
    Arulprakash S; Sasi AD; Bala MR; Pugazhendhi T; Kumar SJ
    J Assoc Physicians India; 2010 Jul; 58():455-6. PubMed ID: 21121216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 38-year-old African-American woman with an unusually rapid progression of "Primary Biliary Cirrhosis": a missed opportunity!
    van Leeuwen DJ; Sood G; Ferrante D; Lazenby AJ; Sellers MJ
    Semin Liver Dis; 2002 Nov; 22(4):395-406. PubMed ID: 12447711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis with unusual initial presentation as fulminant hepatic failure.
    Kayacetin E; Köklü S; Temuçin T
    Dig Liver Dis; 2004 Jun; 36(6):419-22. PubMed ID: 15248383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals.
    Lohse AW; zum Büschenfelde KH; Franz B; Kanzler S; Gerken G; Dienes HP
    Hepatology; 1999 Apr; 29(4):1078-84. PubMed ID: 10094950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laparoscopic features of primary biliary cirrhosis in AMA-positive and AMA-negative patients.
    Fujioka S; Yamamoto K; Okamoto R; Miyake M; Ujike K; Shimada N; Terada R; Miyake Y; Nakajima H; Piao CY; Iwasaki Y; Tanimizu M; Tsuji T
    Endoscopy; 2002 Apr; 34(4):318-21. PubMed ID: 11932789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of serum antimitochondrial antibody-negative primary biliary cirrhosis.
    Zhang FK; Jia JD; Wang BE
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):288-91. PubMed ID: 15138128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis?
    Colombato LA; Alvarez F; Côté J; Huet PM
    Gastroenterology; 1994 Dec; 107(6):1839-43. PubMed ID: 7958699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid.
    Tromm A; May B; Klein CG; Klein R; Fisseler-Eckhoff A; Griga T
    Hepatogastroenterology; 2005; 52(63):753-6. PubMed ID: 15966198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of colchicine in patients with primary biliary cirrhosis poorly responsive to ursodiol and methotrexate.
    Lee YM; Kaplan MM
    Am J Gastroenterol; 2003 Jan; 98(1):205-8. PubMed ID: 12526960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis.
    Poupon R; Chazouilleres O; Corpechot C; Chrétien Y
    Hepatology; 2006 Jul; 44(1):85-90. PubMed ID: 16799997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PBC-AIH overlap syndrome with concomitant ITP and Hashimoto's disease with positivity for anti-centromere antibody.
    Arakawa Y; Amaki S; Miyakawa H; Sakai T; Gotou I; Tanaka N; Moriyama M; Iwasaki A; Sugitani M; Arakawa Y
    J Gastroenterol; 2004; 39(5):490-5. PubMed ID: 15175950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical features of 35 cases of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome].
    Zeng Z; Han YK; Zhang XF; Geng H
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):3-5. PubMed ID: 15670480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence of antinuclear antibodies in primary biliary cirrhosis, with negative antimitochondrial antibodies].
    Antonio Olivera M; Zapata L; Kaplan M; Bobadilla J; Corte G; de la Mora G; Uribe M; Cabiedes J; Dehesa M; Kershenobich D
    Rev Gastroenterol Mex; 1993; 58(3):220-2. PubMed ID: 8165399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.